Why is BIO-RAD LABORATORIES stock price going up?
BIO-RAD LABORATORIES
Bulls say
Product Performance
Process chromatography grew mid-teens percentage in the quarter, and management was constructive on consumables overall.
BIO-RAD LABORATORIES Stock (BIO.re) Price Chart, Analysis, and Forecast
View the real-time BIO-RAD LABORATORIES (BIO.re) stock quote and decide if you want to buy and when to sell. Find predictions, financials, the latest news and other information to help you with your stock investing.
live price
Live Chart
Past performance is not a reliable indicator of future results.
Is BIO-RAD LABORATORIES a good stock to buy?
The quantitative stock rating system created by TipRanks shows that BIO-RAD LABORATORIES price is underperforming. Its Smart Score¹ of 2 indicates BIO-RAD LABORATORIES is not one of the best stocks to buy now.
2
Smart Score
Why is BIO-RAD LABORATORIES stock price going down?
BIO-RAD LABORATORIES
Bears say
Financial Performance
Forecasts for Bio-Rad's revenue and adjusted EBITDA have been reduced, reflecting a less optimistic outlook.
Growth Forecast
Bio-Rad Laboratories is expected to experience lower growth in their Life Sciences segment due to recent US policy changes and uncertainty around NIH funding.
What is happening with
BIO-RAD LABORATORIES stock price today?
The price of BIO-RAD LABORATORIES today, as of , was $. That's down % from the previous session's BIO-RAD LABORATORIES closing price.
The BIO-RAD LABORATORIES price is declining this week. Compared to last week, the rate of BIO-RAD LABORATORIES is down --, and it's down -- from one month ago.
The 52-week BIO-RAD LABORATORIES price high is $, while the 52-week BIO-RAD LABORATORIES price low is $.
Year to date, BIO-RAD LABORATORIES price is down -- from the beginning of the year and has had a return of -- in the last 12 months.
What is the sentiment of BIO-RAD LABORATORIES stock in May 2026?
The sentiment score², indicating how the crowd feels about BIO-RAD LABORATORIES stock is NEGATIVE. The sentiment signal³ observed at the start of the market session, offering insights into whether BIO-RAD LABORATORIES stock price today is likely to increase, decrease, or remain steady, is BEARISH.
News SentimentVery BearishBullish: 0%Bearish: 100%
Blogger OpinionBullishBullish: 100%Bearish: 0%
Investors SentimentVery NegativePast 7d: -1%Past 30d: -3%
Table with the sentiment of BIO-RAD LABORATORIES stock in May 2026
BIO-RAD LABORATORIES stock analysis
Based on analysts giving ratings to BIO-RAD LABORATORIES stock, the consensus⁴ is BUY. Hedge funds activity⁵ decreased in the last quarter, while Insider activity⁶ trend is N/A (N/A BIO-RAD LABORATORIES shares)
BIO-RAD LABORATORIES Technical Analysis
Negative
0.11Simple moving average: 20/200 days
Momentum: 12 month change
BIO-RAD LABORATORIES Insider Activity
No data available
BIO-RAD LABORATORIES Fundamentals
+2.0%+3.0%Return on equity: last 12 months
Asset growth: 12 month change
Discover key BIO-RAD LABORATORIES stock trends with NAGA Insights
What am I Missing?
Make informed decisions based on real-time data, expert analysis, and powerful research tools from TipRanks.
Access advanced BIO-RAD LABORATORIES charting, technical analysis, and live market data from TradingView.
Get AI-powered BIO-RAD LABORATORIES trade signals, in-depth market analysis, and technical strategy insights from Trading Central.
All investing involves risk
BIO-RAD LABORATORIES stock outlook 2026
Analysts forecast BIO-RAD LABORATORIES stock price will rise/fall in the next 12 months. Based on 3 Wall Street analysts offering BIO-RAD LABORATORIES price predictions in the last 3 months, the average price target is $308.33.
The highest BIO-RAD LABORATORIES stock forecast is $335.00, while the lowest is $290.00. The average BIO-RAD LABORATORIES price target represents a 21.24% change from the actual price of $.
BIO-RAD LABORATORIES stock price prediction⁷
- Highest price target$335.00
- Average price target$308.33
- Lowest price target$290.00
BIO-RAD LABORATORIES stock forecast⁸
- Buy33.33%
- Hold66.67%
- Sell0.00%
Overview of stock forecast and price predictions 2026. Analyst price targets and consensus are estimates only and do not constitute guarantees of future outcomes.
Investing in BIO-RAD LABORATORIES stock
There are two ways to invest in BIO-RAD LABORATORIES stock: trading BIO-RAD LABORATORIES stock through derivatives like CFDs or buying shares of BIO-RAD LABORATORIES stock outright. With NAGA.com, you can do both and more.
Buy BIO-RAD LABORATORIES shares of stock if you want to hold them for a long time. You commit the full value of the BIO-RAD LABORATORIES shares outright and profit only if they increase in price.
Trade BIO-RAD LABORATORIES if you want more flexibility — say you want to speculate on its price movements in both directions. With CFDs, you can open a buy position (go long) if you think BIO-RAD LABORATORIES stock’s price will rise, or you can open a sell position (go short) if you believe the BIO-RAD LABORATORIES stock’s price will fall.
You won’t need to commit to the full value of the position. But bear in mind that leverage can increase both your profits and losses.
How to trade BIO-RAD LABORATORIES with CFDs?
If you want to speculate on BIO-RAD LABORATORIES price, search for BIO-RAD LABORATORIES CFD. Then click on the "BIO-RAD LABORATORIES" symbol to view the chart and other insights before placing your trade. Also, review "BIO-RAD LABORATORIES" contract specification to be aware of all the BIO-RAD LABORATORIES CFD trading conditions.
How to buy BIO-RAD LABORATORIES stock?
If you want to buy BIO-RAD LABORATORIES shares outright to hold them for a long time, search for BIO-RAD LABORATORIES stock with ownership (Real Stocks). Then click on the "BIO-RAD LABORATORIES" symbol to view the chart and other insights before placing your trade. Also, review "BIO-RAD LABORATORIES" contract specification to be aware of all the BIO-RAD LABORATORIES stock buying conditions.
trading conditions:
平台
MT5
交易单
交易量阶梯
手数值
最小交易规模
最大交易规模
All investing involves risk
BIO-RAD LABORATORIES company presentation
BIO
Bio-Rad Laboratories
Real Stocks
--
--
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Latest BIO-RAD LABORATORIES stock news
Discover the latest news that can influence BIO-RAD LABORATORIES’s earnings sentiment and BIO-RAD LABORATORIES forecast and price predictions.
FAQs about BIO-RAD LABORATORIES trading
The price of BIO-RAD LABORATORIES stock today, as of , was . That's down % from the previous session's BIO-RAD LABORATORIES closing price.
IMPORTANT NOTICE: The content presented in the instrument page is only for informational, educational and support purposes. The material presented, including analyses, sentiment, consensus, prices, opinions or other content, is not an investment recommendation or information that recommends or suggests an investment strategy, nor is it included in the scope of investment advice. NAGA will not accept liability for any loss or damage, including but not limited to any loss of profits, that may arise directly or indirectly from the use of or reliance on the information contained in this page. NAGA is not responsible for the actions or omissions of the client, especially for the acquisition or disposal of financial instruments, made based on the information contained in this page. Past performance is not necessarily indicative of future results, and anyone acting on this information does so at their own risk. ¹ ⁵ ⁶ The Smart Score is a proprietary quantitative stock scoring system created by TipRanks. It assigns stocks a score from one to ten, based on 8 market key factors. The lowest score is 1, and the highest is 10. Stocks with a score of 8, 9, or 10 are considered Outperform, and with a score of 1, 2, or 3 are considered Underperform. The score is data-driven and does not involve any human intervention. The contributing market factors are Wall Street analyst ratings, Corporate insider transactions, Financial blogger opinions, Individual investor sentiment, Hedge fund manager activity, News sentiment, Technicals and Fundamentals. This information is provided for indicative purposes only and should not be interpreted as investment advice or a recommendation to trade. ⁴ ⁷ ⁸ TipRanks’ consensus ratings provide an aggregated view of expectations and consensus on a particular stock from a wide range of global analyst opinions. They’re then condensed into a single indicator, which can help you make investment decisions based on expert analysis. TipRanks’ 12-month forecast is a consensus price target derived from Wall Street analysts’ projections made over the past three months. It forecasts the potential high, low, and average share price for a stock one year from now, along with the average expected upside or downside percentage. ² ³ The sentiment signal and sentiment score are provided by Trading Central. Sentiment insights and market views are based on available data and do not guarantee future performance.
需要帮忙？前往我们的帮助部分
Download NAGA Trader
Download NAGA Trader
点击二维码以放大
版权 © 2026 – 保留所有权利。
NAGA是德国金融科技公司The NAGA Group AG的商标，该公司在法兰克福证券交易所公开上市 | WKN: A41YCM | ISIN: DE000A41YCM0。
该网站由NAGA Capital Ltd运营，该公司获得塞舌尔金融服务管理局（FSA）授权和监管，许可证号为SD026。注册地址为 Suite 3, Jivan’s Complex, Global Village, Mont Fleuri, Mahe, Seychelles。 Tel: +248 4373121
其他集团实体：NAGA Markets Europe Ltd，获得塞浦路斯证券交易委员会（"CySEC"）授权和监管，许可证号为204/13，注册地址为Agias Zonis 11, Limassol, 3027, Cyprus，以及NAGA Global (CY) Ltd，注册地址为Nikokreontos 2, NICE DREAM, 6th floor, Flat/Office 601, 1066, Nicosia, Cyprus。
风险警告： 衍生品是复杂的工具，由于杠杆作用，存在快速亏损的高风险。您应考虑是否了解衍生品的运作方式以及是否能够承担亏损的高风险。这不是投资建议。通过NAGA Trader跟随和/或复制或复制其他交易者的交易涉及高风险，即使是跟随和/或复制或复制主要交易者的交易。这些风险包括您可能跟随/复制可能没有经验/不专业的交易者的交易决策，或其最终目的或意图或财务状况可能与您不同的交易者。在做出投资决策之前，您应依靠自己对做出交易决策的人的评估以及所有法律文件条款的评估。
受限国家： NAGA Capital Ltd不为某些国家的居民提供服务，例如阿富汗、阿尔巴尼亚、美属萨摩亚、安圭拉、澳大利亚、奥地利、巴巴多斯、白俄罗斯、比利时、百慕大、英属印度洋领地、保加利亚、布基纳法索、加拿大、开曼群岛、中非共和国、圣诞岛、科科斯（基林）群岛、刚果民主共和国、克罗地亚、塞浦路斯、捷克共和国、丹麦、爱沙尼亚、福克兰群岛（马尔维纳斯）、芬兰、法国、德国、直布罗陀、希腊、关岛、海地、赫德岛和麦克唐纳群岛、匈牙利、冰岛、伊朗伊斯兰共和国、爱尔兰、马恩岛、以色列、意大利、牙买加、日本、泽西岛、朝鲜民主主义人民共和国、拉脱维亚、利比亚阿拉伯民众国、列支敦士登、立陶宛、卢森堡、马里、马耳他、蒙特塞拉特、莫桑比克、缅甸、荷兰、新西兰、诺福克岛、挪威、巴勒斯坦被占领土、皮特凯恩、波兰、葡萄牙、罗马尼亚、圣赫勒拿、阿森松和特里斯坦达库尼亚、圣马力诺、塞内加尔、塞尔维亚、斯洛伐克、斯洛文尼亚、索马里、南乔治亚和南桑威奇群岛、南苏丹、西班牙、斯里兰卡、瑞典、瑞士、阿拉伯叙利亚共和国、特立尼达和多巴哥、突尼斯、特克斯和凯科斯群岛、乌干达、英国及任何其他拥有英国身份证明的国家（即英属维尔京群岛、直布罗陀、马恩岛等）、美国、美国小离岛、瓦努阿图、英属维尔京群岛、美属维尔京群岛、也门和津巴布韦。